IL134210A0 - Use of transcription factor brn-3a - Google Patents

Use of transcription factor brn-3a

Info

Publication number
IL134210A0
IL134210A0 IL13421098A IL13421098A IL134210A0 IL 134210 A0 IL134210 A0 IL 134210A0 IL 13421098 A IL13421098 A IL 13421098A IL 13421098 A IL13421098 A IL 13421098A IL 134210 A0 IL134210 A0 IL 134210A0
Authority
IL
Israel
Prior art keywords
transcription factor
factor brn
brn
transcription
factor
Prior art date
Application number
IL13421098A
Other languages
English (en)
Original Assignee
Neurovex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9715823.2A external-priority patent/GB9715823D0/en
Application filed by Neurovex Ltd filed Critical Neurovex Ltd
Publication of IL134210A0 publication Critical patent/IL134210A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL13421098A 1997-07-25 1998-07-27 Use of transcription factor brn-3a IL134210A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9715823.2A GB9715823D0 (en) 1997-07-25 1997-07-25 Use of transcription factor BRN-3A
US98847697A 1997-12-10 1997-12-10
PCT/GB1998/002228 WO1999005272A1 (en) 1997-07-25 1998-07-27 Use of transcription factor brn-3a

Publications (1)

Publication Number Publication Date
IL134210A0 true IL134210A0 (en) 2001-04-30

Family

ID=26311947

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13421098A IL134210A0 (en) 1997-07-25 1998-07-27 Use of transcription factor brn-3a

Country Status (6)

Country Link
EP (1) EP1003859A1 (xx)
JP (1) JP2001511344A (xx)
AU (1) AU8548198A (xx)
CA (1) CA2298107A1 (xx)
IL (1) IL134210A0 (xx)
WO (1) WO1999005272A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9819999D0 (en) * 1998-09-14 1998-11-04 Univ London Treatment of cancer
EP1151094A1 (en) * 1998-12-07 2001-11-07 University College London Cervical cancer treatment
CA2443123A1 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
KR100820072B1 (ko) * 2002-12-28 2008-04-10 (주)아모레퍼시픽 진세노사이드 Ｆ1을 유효성분으로 하는 Ｂｃｌ-2 발현조절제
JP3870921B2 (ja) 2003-04-01 2007-01-24 セイコーエプソン株式会社 非接触識別タグ
KR100868905B1 (ko) * 2004-03-26 2008-11-14 (주)아모레퍼시픽 진세노사이드 ｆ1과 ｅｇｃｇ을 함유한 자외선 조사로유도되는 피부손상 방지용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9615794D0 (en) * 1996-07-26 1996-09-04 Medical Res Council Mutant herpes simplex virus strains and uses thereof

Also Published As

Publication number Publication date
WO1999005272A9 (en) 1999-10-28
CA2298107A1 (en) 1999-02-04
JP2001511344A (ja) 2001-08-14
WO1999005272A1 (en) 1999-02-04
AU8548198A (en) 1999-02-16
EP1003859A1 (en) 2000-05-31

Similar Documents

Publication Publication Date Title
PL339551A1 (en) Derivatives of rezorcin
PL329875A1 (en) Derivatives of carbolin
PL329195A1 (en) Derivatives of 6-phenylpyridol-2-amine
GB9526560D0 (en) Use of 2-Amino-Heterocycles
IL126272A0 (en) Synthesis of indolylmaleimides
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
HU9700071D0 (en) Use of muramilpeptides
ZA96725B (en) Use of phenyclyclohexylcarboxamides
IL128376A0 (en) Synthesis of bisindolylmalimides
HU9702480D0 (en) New polymorphe modification of doxazosin-mesylate
IL134210A0 (en) Use of transcription factor brn-3a
HUP9800146A3 (en) Thalidomide-derivatives and use of them
GB9602704D0 (en) Structure of perculator
PL334769A1 (en) Derivatives of 5-aroylnaphtene
GB9724829D0 (en) Transcription factor
GB2328397B (en) Manufacture of elongate members
HU9702479D0 (en) New polymorphe modification of doxazosin-mesylate
ZA985064B (en) Derivatives of pentaerythrits
GB9600559D0 (en) Use of chemokines
GB9715823D0 (en) Use of transcription factor BRN-3A
GB9700946D0 (en) Manufacture of elongate members
PL325816A1 (en) Novel derivatives of naphtylpiperazine
EP0923519A4 (en) PRODUCTION OF HALOALKYNOLS
PL313849A1 (en) Beta-aminoesters of o-hydrobenzylamides
TW312301U (en) Improved structure of earmask